Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

At clinically relevant doses, AAV.SPR efficiently transduces foveal cones without the need for surgical detachment and does not cause inflammation. For more information about the preclinical study ...

ATSN-201, a best-in-class gene therapy product candidate, leverages AAV.SPR, the company's novel spreading capsid, to achieve therapeutic levels of gene expression in photoreceptors of the central ...

FULL thickness Macular hole (FTMH) is a condition where there is an anatomic defect in the continuity of the foveal retina. In this condition, the patient will likely experience distortion of ...

Both in the superficial and deep retina, decreased macular flow density was found in the PM group compared with the HM and EM groups, except in the foveal region and the deep temporal and deep nasal ...

Optometrists may not surgically repair macular holes, but they play a crucial role in managing visual outcomes in these ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Participants with macular oedema were excluded ... and standard field 2 (centred on the fovea) of each eye.22 The fundus photographs were assessed for the presence of DR and DR severity by the ...

Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...